The MLL recombinome of acute leukemias in 2017

Claus Meyer, Thomas Burmeister, Daniela Gröger, +66

Leukemia

The MLL recombinome of acute leukemias in 2013

Claus Meyer, Jörg Hofmann, Thomas Burmeister, +82

Leukemia

Differential Effects of Notch Ligands Delta-1 and Jagged-1 in Human Lymphoid Differentiation

Ana C. Jaleco, Hélia Neves, Erik Hooijberg, +4

The Journal of Experimental Medicine

Lymphocyte DevelopmentT-regulatory CellImmunologyImmune RegulationNk Cells +17

Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemia

MJ Pongers-Willemse, Taku Seriu, Frank Stolz, +9

Leukemia

Hematological MalignancyLymphoid NeoplasiaMedicineMixed-phenotype Acute LeukemiaImmunology +10

Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

Paul Evans, Ch Pott, Patricia J.T.A. Groenen, +29

Leukemia

B-cell MalignanciesLymphoid NeoplasiaHematological MalignancyMedicineImmunology +5

Improved reliability of lymphoma diagnostics via PCR-based clonality testing: — Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

J. Han van Krieken, Anton W. Langerak, Elizabeth Macintyre, +24

Leukemia

Lymphoid NeoplasiaOncologyEngineeringCancer DetectionPcr-based Clonality Testing +12

Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936

Monika Brüggemann, Harry N White, Philippe Gaulard, +24

Leukemia

Lymphoid NeoplasiaOncologyT-cell Malignancies ReportTumor HeterogeneityMedicine +11

The KMT2A recombinome of acute leukemias in 2023

Claus Meyer, Patrizia Larghero, Bruno A. Lopes, +63

Leukemia

Minimal Residual Disease Tests Provide an Independent Predictor of Clinical Outcome in Adult Acute Lymphoblastic Leukemia

Forida Y. Mortuza, Mary Papaioannou, Ilidia M. Moreira, +7

Journal of Clinical Oncology

Mrd PositivityMolecular MarkersMixed-phenotype Acute LeukemiaImmunodeficienciesImmunology +20

Targeting CK2 overexpression and hyperactivation as a novel therapeutic tool in chronic lymphocytic leukemia

Leila R. Martins, Paulo Lúcio, Milene Costa da Silva, +4

Blood